Top 10 at 10: ASX stocks rocket on positive clinical studies, shallow gold, and high grade niobium

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Biotech INOVIQ Limited (ASX:IIQ) says its Ovarian Cancer 97 study (OC97) has been completed by the Centre for Clinical Research, The University of Queensland (UQ).

It confirmed “the utility of EXO-NET for EV biomarker discovery and generation of a multivariate index assay (MIA) with over 90% accuracy for the detection of early-stage ovarian cancer”.

Recent infill drilling (to increase confidence in a resource) is hitting shallow, high grade gold at Kingwest Resources’ (ASX:KWR) flagship Menzies project.

The company has also identified shallow high-grade subsets of the Pericles and Stirling deposits, with 45,000oz at 5.2g/t within 100m of surface.

These high-grade resources are considered amenable to open pit mining, KWR says.

And Reach Resources (ASX:RR1) has picked up rocks containing high-grade REEs, niobium and tantalum at its Skyline and Critical Elements projects, both in WA.

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).